98%
921
2 minutes
20
This century has witnessed unprecedented increasing interest in the investigation of emotion-cognition interactions and the associated neural mechanisms. The present review emphasizes the need to consider the various factors that can influence enhancing and impairing effects of emotion on cognition, in studies of both healthy and clinical groups. First, we discuss advances in understanding the circumstances in which emotion enhances or impairs cognition at different levels, both (e.g., perception, episodic memory) and (i.e., episodic vs. working memory). Then, we discuss evidence regarding these opposing effects of emotion in a larger context, of the and linked to the role of individual differences (personality, genetic) affecting stress sensitivity. Finally, we also discuss evidence linking these opposing effects of emotion in a (PTSD), where they are both deleterious, and based on comparisons with opposing affective biases: healthy aging () vs. depression (). These issues have relevance for understanding mechanisms of emotion-cognition interactions in healthy functioning and in psychopathology, which can inspire training interventions to increase resilience and well-being.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12116453 | PMC |
http://dx.doi.org/10.3389/fpsyg.2025.1483373 | DOI Listing |
J Med Internet Res
September 2025
Center for Healthy Minds and Department of Counseling Psychology, University of Wisconsin-Madison, Madison, WI, United States.
Background: Ecological momentary assessment (EMA) is increasingly being incorporated into intervention studies to acquire a more fine-grained and ecologically valid assessment of change. The added utility of including relatively burdensome EMA measures in a clinical trial hinges on several psychometric assumptions, including that these measure are (1) reliable, (2) related to but not redundant with conventional self-report measures (convergent and discriminant validity), (3) sensitive to intervention-related change, and (4) associated with a clinically relevant criterion of improvement (criterion validity) above conventional self-report measures (incremental validity).
Objective: This study aimed to evaluate the reliability, validity, and sensitivity to change of conventional self-report versus EMA measures of rumination improvement.
Cuad Bioet
September 2025
Facultad de Farmacia y Nutrición de la Universidad de Navarra, Irunlarrea, 1, 31008 Pamplona.
In recent years, there has been a significant increase in minors with gender dysphoria (GD) seeking transition treatments, including puberty blockers and cross-sex hormones. The developing child's brain exhibits structural and functional differences in children with GD compared to cisgender children, particularly in areas where sex differences exist. Brain development during childhood and adolescence is strongly influenced by sex hormones.
View Article and Find Full Text PDFBrain
September 2025
Aix Marseille Univ, INSERM, INS, Inst Neurosci Syst, 13005 Marseille, France.
The lateral prefrontal cortex (LPFC) serves as a critical hub for higher-order cognitive and executive functions in the human brain, coordinating brain networks whose disruption has been implicated in many neurological and psychiatric disorders. While transcranial brain stimulation treatments often target the LPFC, our current understanding of connectivity profiles guiding these interventions based on electrophysiology remains limited. Here, we present a high-resolution probabilistic map of bidirectional effective connectivity between the LPFC and widespread cortical and subcortical regions.
View Article and Find Full Text PDFPLoS One
September 2025
Faculdade de Psicologia, Universidade de Lisboa, Lisboa, Portugal.
Background: Self-leadership has been associated with several positive organizational outcomes (e.g., performance and innovation).
View Article and Find Full Text PDFClin Exp Rheumatol
September 2025
Rheumatology Unit, Azienda Ospedaliero-Universitaria Pisana, Pisa, Italy.
Behçet's disease (BD) is a rare multisystemic vasculitis that significantly impacts patients' quality of life. Effective management of BD requires a patient-centred approach that empowers individuals to actively participate in their care. This work explores the importance of patient empowerment, adherence to treatment, and patient education in BD.
View Article and Find Full Text PDF